Evidence map›Paper›PMID 30637455›Full record

ArticleHistochemistry and cell biology2019

Osteoclasts secrete osteopontin into resorption lacunae during bone resorption.

Jani Luukkonen, Meeri Hilli, Miho Nakamura, Ilja Ritamo, Leena Valmu, Kyösti Kauppinen, Juha Tuukkanen, Petri Lehenkari

Open access · hybridAbstract read
In one paragraph

Article in Histochemistry and cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Metabolomic biomarkers of low BMD: a systematic review.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Pooled it
  2. Effects of teriparatide on hip structure and bone microarchitecture in women with anorexia nervosa: a placebo-controlled randomized trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Extracellular derivatives for bone metabolism.Journal of advanced research · 2024
    Review
  10. Article
  11. Review
  12. High-ResolutionAnalytical chemistry · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Dichotomous Roles ofInternational journal of molecular sciences · 2022
    Article
  18. Article
  19. Regulation ofFrontiers in pediatrics · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jani LuukkonenDepartment of Anatomy and Cell Biology, Cancer Research and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, P.O. Box 5000, Aapistie 5, 90014, Oulu, Finland. jani.luukkonen@oulu.fi.ORCID http://orcid.org/0000-0001-9643-7087
Meeri HilliDepartment of Anatomy and Cell Biology, Cancer Research and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, P.O. Box 5000, Aapistie 5, 90014, Oulu, Finland.
Miho NakamuraDepartment of Anatomy and Cell Biology, Cancer Research and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, P.O. Box 5000, Aapistie 5, 90014, Oulu, Finland.
Ilja RitamoThermo Fisher Scientific Oy, Ratastie 2, 01620, Vantaa, Finland.
Leena ValmuThermo Fisher Scientific Oy, Ratastie 2, 01620, Vantaa, Finland.
Kyösti KauppinenDepartment of Anatomy and Cell Biology, Cancer Research and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, P.O. Box 5000, Aapistie 5, 90014, Oulu, Finland.
Juha TuukkanenDepartment of Anatomy and Cell Biology, Cancer Research and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, P.O. Box 5000, Aapistie 5, 90014, Oulu, Finland.
Petri LehenkariDepartment of Anatomy and Cell Biology, Cancer Research and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, P.O. Box 5000, Aapistie 5, 90014, Oulu, Finland.
University of Oulu · FIThermo Fisher Scientific (Finland) · FITokyo Medical and Dental University · JP

Funding

Biotieteiden ja Ymp?rist?n Tutkimuksen Toimikunta 130795Grant for Basic Science Research Projects from The Sumitomo Foundation -Grants-in-Aid for the Promotion of Joint International Research 15KK0299Northern Ostrobothnia Hospital DIstrict Research Funding -Tekes -The National Doctoral Programme of Musculoskeletal Disorders and Biomaterials -
6 · The paper itself

Abstract

Osteopontin (OPN) is a non-collagenous extracellular sialylated glycoprotein located in bone. It is believed to be one of the key components in osteoclast attachment to bone during resorption. In this study, we characterized OPN and other glycoproteins found in the resorption lacunae to confirm the role of osteoclasts in OPN secretion using electron microscopy and mass spectrometry. Additionally, we examined the glycan epitopes of resorption pits and the effects of different glycan epitopes on the differentiation and function of osteoclasts. Osteoarthritic femoral heads were examined by immunohistochemistry to reveal the presence of OPN in areas of increased bone metabolism in vivo. Our results demonstrate that human osteoclasts secrete OPN into resorption lacunae on native human bone and on carbonated hydroxyapatite devoid of natural OPN. OPN is associated with an elevated bone turnover in osteoarthritic bone under experimental conditions. Our data further confirm that osteoclasts secrete OPN into the resorption pit where it may function as a chemokine for subsequent bone formation. We show that α2,3- and α2,6-linked sialic acids have a role in the process of osteoclast differentiation. OPN is one of the proteins that has both of the above sialic residues, hence we propose that de-sialylation can effect osteoclast differentiation in bone.

Indexed as

Bone ResorptionAnimalsCell DifferentiationFemur HeadHumansMass SpectrometryMicroscopy, ElectronOsteoclastsOsteopontinSialic AcidsOsteopontinSialic AcidsBone resorptionGlycan epitopeLectinOsteoclastOsteopontinSialic acid

Identifiers

PMID30637455
PMCPMC6542781
OpenAlexW2908924352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.